Products & Services

The following products and services are offered by the subsidiaries of Sekhmet Pharmaventures, namely Anjan Drug Private Limited and Optimus Drugs Private Limited

Amorolfine Cream

Anti-fungal

Strength
0.25% w/w

Route of Administration
Topical Dosage Form

Brivaracetam

Anti-convulsant

Strength
10 mg ,25 mg ,50 mg ,75 mg, & 100 mg

Route of Administration
Oral Dosage Form

Dabigatran Etexilate Capsules

Anti-coagulant

Strength
75 mg, 110 mg and 150 mg

Route of Administration
Oral Dosage Form

Dexlansoprazole Dual Delayed Release Capsules

Proton Pump Inhibitor

Strength
30 mg and 60 mg

Route of Administration
Oral Dosage Form

Eberconazole and Mometasone Furoate Cream

Anti-fungal

Strength
1% and 0.1% w/w

Route of Administration
Topical Dosage Form

Eberconazole Cream

Anti-fungal

Strength
1% w/w

Route of Administration
Topical Dosage Form

Favipiravir Tablets

Anti-viral

Strength
200 mg, 400 mg and 800 mg

Route of Administration
Oral Dosage Form

Fenticonazole Nitrate 2% cream

Anti-fungal

Strength
2% w/w

Route of Administration
Topical Dosage Form

Fenticonazole Nitrate Vaginal Capsules

Anti-fungal

Strength
600 mg Soft Gel

Route of Administration
Infra vaginal Form

Linezolid Tablets IP

Anti-bacterial

Strength
600 mg

Route of Administration
Oral Dosage Form

Luliconazole Cream

Anti-fungal

Strength
1% w/w

Route of Administration
Topical Dosage Form

Luliconazole Lotion

Anti-fungal

Strength
1% w/v

Route of Administration
Topical Dosage Form

Molnupiravir

Covid – 19

Strength
200 mg, 400 mg and 800 mg

Route of Administration
Oral Dosage Form

Obeticholic Acid Tablets

Choleretic agent

Strength
5 mg and 10 mg

Route of Administration
Oral Dosage Form

Oxiconazole Nitrate Cream

Anti-fungal

Strength
1% w/w

Route of Administration
Topical Dosage Form

Oxiconazole Nitrate Lotion

Anti-fungal

Strength
1% w/v

Route of Administration
Topical Dosage Form

Ozenoxacin

Anti-bacterial

Strength
1%

Route of Administration
Topical Dosage Form

Pirfenidone Tablets IP

Anti-fibrotic

Strength
200 mg

Route of Administration
Oral Dosage Form

Rifaximin Suspension

Anti-biotic

Strength
100 mg / 5 ml

Route of Administration
Oral Dosage Form

Rifaximin Tablets

Anti-biotic

Strength
200 mg, 400 mg and 550 mg

Route of Administration
Oral Dosage Form

Rivaroxaban Tablets

Stroke and Systemic

Strength
2.5 mg, 10 mg, 15 mg and 20 mg

Route of Administration
Oral Dosage Form

Sertaconazole Nitrate + ZPTO Shampoo

Anti-fungal

Strength
2.0% w/v

Route of Administration
Topical Dosage Form

Sertaconazole Nitrate Cream

Anti-fungal

Strength
2.0% w/w

Route of Administration
Topical Dosage Form

Sertaconazole Nitrate Lotion

Anti-fungal

Strength
2.0% w/v

Route of Administration
Topical Dosage Form

Silodosin and Dutasteride Capsules

Bengin Prostatic Hyperplasia (BPH)

Strength
4 mg+0.5 mg and 8 mg +0.5 mg

Route of Administration
Oral Dosage Form

Silodosin Capsules

Bengin Prostatic Hyperplasia (BPH)

Strength
4 mg and 8 mg

Route of Administration
Oral Dosage Form

Tofacitinib

Janus kinase (JAK) inhibitor

Strength
5 mg, 10 mg, 11mg ER and 22 mg ER

Route of Administration
Oral Dosage Form

Ursodeoxycholic Acid Tablets

Biliary Cirrhosis

Strength
150 and 300 mg

Route of Administration
Oral Dosage Form

Vildagliptin

Anti-Diabetic

Strength
50 mg and 100 mg SR

Route of Administration
Oral Dosage Form

Vildagliptin + Metformin

Anti-Diabetic

Strength
50 mg+ 500 mg, 850 mg, 1000 mg, 500 mg SR, 1000 mg SR

Route of Administration
Oral Dosage Form

Aminocaproic acid

Anti-fibrinolytic agent

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Amorolfine

Anti-fungal

DMF
Available

Apixaban

Anti-coagulant

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Bempedoic acid

Lipid Lowering Agents

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Bilastine

Anti-histamine

DMF
Available

Bucillamine

Anti-Inflammatory

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

D-Penicillamine

Anti-Rheumatic

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Dabigatran Etexilate Mesylate

Anti-coagulant

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Dapagliflozin amorphous

Anti-diabetic

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Dapagliflozin propanediol

Anti-diabetic

DMF
Available

Dapoxetine

Anti-Depressant

DMF
Available

Dexlansoprazole

Anti-fungal

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Dimethyl Fumarate

Multiple Sclerosis

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Dithranol

Anti-Psoriatic

Pharmacopeia
EP

EDQM EU
Approved

DMF
Available

Divalproex Sodium

Anti-epileptic

Pharmacopeia
IP, USP

Eberconazole nitrate

Anti-fungal

DMF
Available

Eletriptan hydrobromide

Anti-Migraine

DMF
Available

Empagliflozin

Anti-Diabetic

DMF
Available

Ethacizine Hydrochloride

Anti-Arrhythmic

DMF
Available

Favipiravir

Anti-viral

DMF
Available

Fenticonazole nitrate

Anti-fungal

Pharmacopeia
EP

EDQM EU
Approved

DMF
Available

Gabapentin

Anti-convulsant

Pharmacopeia
USP, ChP, BP, EP, IP

DMF
Available

Linagliptin

Anti-Diabetic

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Linezolid Form I

Anti-Bacterial

DMF
Available

Linezolid Form II

Anti-Bacterial

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Lornoxicam

Anti-Inflammatory

DMF
Available

Luliconazole

Anti-fungal

DMF
Available

Magnesium Valproate

Anti-convulsant

Pharmacopeia
ChP

Mebendazole Form-A

Anti-fungal

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Mesalamine

Aminosalicylates

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Midodrine

Anti-hypotensive

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Molnupiravir

Anti-Viral

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Montelukast

Anti-Allergic

DMF
Available

Nabilone

Anti-Emetic

DMF
Available

Obeticholic acid

Semi-Synthetic Bile Acid

USFDA US
Approved

DMF
Available

Ozenoxacin

Anti-Biotic

DMF
Available

Phenyramidol hydrochloride

Muscle Relaxant

Pharmacopeia
EP

EDQM EU
Approved

DMF
Available

Pirfenidone

Anti-Fibrotic

Pharmacopeia
USP, EP

USFDA US
Approved

EDQM EU
Approved

DMF
Available

Pregabalin

Anti-convulsant

Pharmacopeia
EP, IP, USP

Pregabalin

Anti-Convulsant

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Rifaximin

Anti-Biotic

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Rivaroxaban

Anti-Coagulant

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Rosuvastatin Calcium

Anti-lipemic

DMF
Available

Safinamide

Anti-Parkinson

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Sertaconazole

Anti-Fungal

DMF
Available

Sitagliptin Phosphate

Anti-Diabetic

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Sodium Valproate

Anti- epileptics Anti-convulsant

Pharmacopeia
IP, JP, ChP, BP, EP

Solifenacin succinate

Urinary Disease

Pharmacopeia
USP, EP

DMF
Available

Teriflunomide

Multiple Sclerosis

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Tioconazole

Anti-Fungal

Pharmacopeia
EP

EDQM EU
Approved

DMF
Available

Tofacitinib

Janus kinase (JAK) inhibitor

DMF
Available

Tranylcypromine sulfate

Anti-Depressant

DMF
Available

Valproic Acid

Anti-convulsant

Pharmacopeia
EP, BP

Vildagliptin

Anti-Diabetic

DMF
Available

Zileuton

Anti-Inflammatory

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Abiraterone

Oncology

Intermediate
(3S,8R,9S,10R,13S,14S)-17-Iodo-10,13-dimethyl-2,3,4,7,8,9, 10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
CAS: 32138-69-5

Intermediate 2
3-Diethylboranyl-pyridine
CAS: 89878-14-8

Apixaban

Anti-coagulant

Intermediate
Ethyl chloro [(4-methoxyphenyl) hydrazono] acetate
CAS: 27143-07-3

Intermediate 2
3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone
CAS: 536760-29-9

Intermediate 3
1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridone
CAS: 1267610-26-3

Intermediate 4
5,6 - dihydro-3-(4-morpholin-yl)-1-(4-nitrophenyl)-2 (1H)-pyridone
CAS: 503615-03-0

Apremilast

Anti-inflammatory

Intermediate
2-(3-ethoxy-4-methoxyphenyl)-1-(methyl sulfonyl)eth-2-ylamine
CAS: 253168-94-4

Intermediate 2
3-Acetamidophthalic anhydride
CAS: 6296-53-3

Atazanavir

Anti-retroviral

Intermediate
N’-(4-Pyridin-2-yl-benzyl)-hydrazine carboxylic acid butyl ester
CAS: 198904-85-7

Intermediate 2
(2R,3S)-3-tert-butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane
CAS: 98760-08-8

Intermediate 3
N-Methoxycarbonyl-L-tert Leucine
CAS: 162537-11-3

Clobazam

Anti-convulsant

Intermediate
5-chloro-2-nitro-N-phenylaniline
CAS: 25781-92-4

Intermediate 2
Monoethyl malonate potassium salt
CAS: 6148-64-7

Dabigatran Etexylate Mesylate

Anti-coagulant

Intermediate
3-[(3-amino-4-methylamino-benzoyl)-pyridin-2-yl-amino]- propionic acid ethyl ester
CAS: 212322-56-0

Intermediate 2
N-(4-cyanophenyl)-glycine
CAS: 42288-26-6

Eletriptan HBr

Anti-Migraine

Intermediate
(R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole
CAS: 143322-57-0

Eltrombopag

Thrombopoietin

Intermediate
3'-Amino-2'-hydroxybiphenyl-3-carboxylic acid
CAS: 376592-93-7

Intermediate 2
2-(3,4-dimethylphenyl)-5-methyl- 2,4-dihydro-3H-pyrazol-3-one
CAS: 277299-70-4

Enzalutamide

Oncology

Intermediate
4-[(2-Cyanopropan-2-yl)amino]-2-fluoro-N-methylbenzamide
CAS: 915087-32-0

Intermediate 2
4-Isothiocyanato-2-(trifluoromethyl)benzo nitrile
CAS: 143782-23-4

Lurasidone

Anti-psychotics

Intermediate
(3aR, 4S, 7R, 7aS)-4,7-methano-1H-isoindole-1,3-(2H)-dione
CAS: 14805-29-9

Intermediate 2
(1R,2R)-1,2-cyclohexanedimethanol
CAS: 65376-05-8

Intermediate 3
(R,R)-1,2-bis(methanesulfonyloxymethyl) cyclohexane
CAS: 186204-35-3

Macitentan

Anti-hypertensive

Intermediate
Propylsulfamide
CAS: 147962-41-2

Intermediate 2
4,6-Dichloro-5-(4-bromophenyl)pyrimidine
CAS: 146533-41-7

Intermediate 3
5-Bromo-2-chloropyrimidine
CAS: 32779-36-5

Mirabegron

Anti-cholinergics

Intermediate
(R)-2-(4-nitrophenyl)ethyl amino)-1-phenylethanol hydrochloride
CAS: 521284-21-9

Intermediate 2
alphaR)-alpha-[[[2-(4-nitrophenyl)ethyl] amino]methyl]benzene methanol
CAS: 223673-34-5

Pirfenidone

Anti-fibrotic

Intermediate
2-Hydroxy-5-methylpyridine
CAS: 1003-68-5

Rivaroxaban

Stroke and Systemic

Intermediate
4-(4-Aminophenyl)morpholin-3-one
CAS: 438056-69-0

Solifenacin Succinate

Urinary Disease

Intermediate
(S)-1-Phenyl-1,2,3,4-Tetrahydro isoquinoline
CAS: 118864-75-8

Teriflunomide

Multiple Sclerosis

Intermediate
5-Methylisoxazole -4-carboxylic acid
CAS: 42831-50-5

As drug molecules get more complex, more innovators and generic manufacturers alike are turning to our CMO/CDMO services, to provide turnkey solutions to streamline their processes and optimize their production. Right from the pre-formulation activities such as development of intermediates, APIs, to development of formulations, conducting and passing Bioequivalence studies and clinical trials, manufacturing of the product as per the regulations of the target market, packaging the product as per guidelines, and bringing products to market whether it is to add a new molecule altogether or a drug variation to their existing product portfolio.

The Sekhmet Pharmaventures group has the unique advantage of being a one stop solution for the entire set of CMO/CDMO requirements. We are vertically integrated with expertise in the entire value chain of drug manufacturing right from Intermediates to final formulations, making the group unprecedented in maintaining quality, timeliness and cost.

Services include :

IP Evaluation
Development of Intermediates, APIs
Formulation
Analytical Services
Pilot Bio Studies
Process Transfer & Scale up Feasibility
Process Validation
Analytical Method Verification services
Stability studies
Packaging, Serialization and Aggregation

Amorolfine Cream

Anti-fungal

Strength 0.25% w/w

Route of Administration Topical Dosage Form

Brivaracetam

Anti-convulsant

Strength 10 mg ,25 mg ,50 mg ,75 mg, & 100 mg

Route of Administration Oral Dosage Form

Dabigatran Etexilate Capsules

Anti-coagulant

Strength 75 mg, 110 mg and 150 mg

Route of Administration Oral Dosage Form

Dexlansoprazole Dual Delayed Release Capsules

Proton Pump Inhibitor

Strength 30 mg and 60 mg

Route of Administration Oral Dosage Form

Eberconazole and Mometasone Furoate Cream

Anti-fungal

Strength 1% and 0.1% w/w

Route of Administration Topical Dosage Form

Eberconazole Cream

Anti-fungal

Strength 1% w/w

Route of Administration Topical Dosage Form

Favipiravir Tablets

Anti-viral

Strength 200 mg, 400 mg and 800 mg

Route of Administration Oral Dosage Form

Fenticonazole Nitrate 2% cream

Anti-fungal

Strength 2% w/w

Route of Administration Topical Dosage Form

Fenticonazole Nitrate Vaginal Capsules

Anti-fungal

Strength 600 mg Soft Gel

Route of Administration Infra vaginal Form

Linezolid Tablets IP

Anti-bacterial

Strength 600 mg

Route of Administration Oral Dosage Form

Luliconazole Cream

Anti-fungal

Strength 1% w/w

Route of Administration Topical Dosage Form

Luliconazole Lotion

Anti-fungal

Strength 1% w/v

Route of Administration Topical Dosage Form

Molnupiravir

Covid – 19

Strength 200 mg, 400 mg and 800 mg

Route of Administration Oral Dosage Form

Obeticholic Acid Tablets

Choleretic agent

Strength 5 mg and 10 mg

Route of Administration Oral Dosage Form

Oxiconazole Nitrate Cream

Anti-fungal

Strength 1% w/w

Route of Administration Topical Dosage Form

Oxiconazole Nitrate Lotion

Anti-fungal

Strength 1% w/v

Route of Administration Topical Dosage Form

Ozenoxacin

Anti-bacterial

Strength 1%

Route of Administration Topical Dosage Form

Pirfenidone Tablets IP

Anti-fibrotic

Strength 200 mg

Route of Administration Oral Dosage Form

Rifaximin Suspension

Anti-biotic

Strength 100 mg / 5 ml

Route of Administration Oral Dosage Form

Rifaximin Tablets

Anti-biotic

Strength 200 mg, 400 mg and 550 mg

Strength
0.25% w/w

Route of Administration
Topical Dosage Form

Strength
10 mg ,25 mg ,50 mg ,75 mg, & 100 mg

Route of Administration
Oral Dosage Form

Strength
75 mg, 110 mg and 150 mg

Route of Administration
Oral Dosage Form

Strength
30 mg and 60 mg

Route of Administration
Oral Dosage Form

Strength
1% and 0.1% w/w

Route of Administration
Topical Dosage Form

Strength
1% w/w

Route of Administration
Topical Dosage Form

Strength
200 mg, 400 mg and 800 mg

Route of Administration
Oral Dosage Form

Strength
2% w/w

Route of Administration
Topical Dosage Form

Strength
600 mg Soft Gel

Route of Administration
Infra vaginal Form

Strength
600 mg

Route of Administration
Oral Dosage Form

Strength
1% w/w

Route of Administration
Topical Dosage Form

Strength
1% w/v

Route of Administration
Topical Dosage Form

Strength
200 mg, 400 mg and 800 mg

Route of Administration
Oral Dosage Form

Strength
5 mg and 10 mg

Route of Administration
Oral Dosage Form

Strength
1% w/w

Route of Administration
Topical Dosage Form

Strength
1% w/v

Route of Administration
Topical Dosage Form

Strength
1%

Route of Administration
Topical Dosage Form

Strength
200 mg

Route of Administration
Oral Dosage Form

Strength
100 mg / 5 ml

Route of Administration
Oral Dosage Form

Strength
200 mg, 400 mg and 550 mg

Route of Administration
Oral Dosage Form

Strength
2.5 mg, 10 mg, 15 mg and 20 mg

Route of Administration
Oral Dosage Form

Strength
2.0% w/v

Route of Administration
Topical Dosage Form

Strength
2.0% w/w

Route of Administration
Topical Dosage Form

Strength
2.0% w/v

Route of Administration
Topical Dosage Form

Strength
4 mg+0.5 mg and 8 mg +0.5 mg

Route of Administration
Oral Dosage Form

Strength
4 mg and 8 mg

Route of Administration
Oral Dosage Form

Strength
5 mg, 10 mg, 11mg ER and 22 mg ER

Route of Administration
Oral Dosage Form

Strength
150 and 300 mg

Route of Administration
Oral Dosage Form

Strength
50 mg and 100 mg SR

Route of Administration
Oral Dosage Form

Strength
50 mg+ 500 mg, 850 mg, 1000 mg, 500 mg SR, 1000 mg SR

Route of Administration
Oral Dosage Form

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

DMF
Available

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

DMF
Available

Pharmacopeia
USP

USFDA US
Approved

DMF
Available

Pharmacopeia
USP